RCKT
Rocket Pharmaceuticals Inc
NASDAQ: RCKT · HEALTHCARE · BIOTECHNOLOGY
$3.64
-5.82% today
Updated 2026-06-05
Market cap
$315.57M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.87
Dividend yield
—
52W range
$2 – $5
Volume
3.1M
Rocket Pharmaceuticals Inc (RCKT) Insider transactions
Net insider activity
Net buying (5,148,100 shares)
Buy transactions
51
Sell transactions
49
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-13 | WILSON, MARTIN | General Counsel | Sale | 3,361 | $3.61 | $12119.77 |
| 2026-05-13 | SHAH, GAURAV | CEO | Sale | 2,728 | $3.61 | $9837.17 |
| 2026-05-13 | MILITELLO, JOHN | See Remarks | Sale | 855 | $3.61 | $3083.13 |
| 2026-05-07 | CHAUDHURI, SARBANI | See Remarks | Sale | 17,650 | $3.84 | $67740.70 |
| 2026-02-18 | WILSON, MARTIN | General Counsel | Sale | 1,376 | $3.34 | $4593.09 |
| 2026-02-18 | SHAH, GAURAV | CEO | Sale | 5,990 | $3.34 | $19994.62 |
| 2026-02-18 | MILITELLO, JOHN | See Remarks | Sale | 1,157 | $3.34 | $3862.07 |
| 2026-02-13 | WILSON, MARTIN | General Counsel | Sale | 12,253 | $3.31 | $40581.94 |
| 2026-02-13 | SHAH, GAURAV | CEO | Sale | 12,279 | $3.31 | $40668.05 |
| 2026-02-13 | MILITELLO, JOHN | See Remarks | Sale | 3,726 | $3.31 | $12340.51 |
| 2026-02-11 | WILSON, MARTIN | General Counsel | Buy | 468,187 | — | — |
| 2026-02-11 | WILSON, MARTIN | General Counsel | Buy | 311,813 | — | — |
| 2026-02-11 | STEVENS, CHRISTOPHER JAMES | Chief Operating Officer | Buy | 93,037 | — | — |
| 2026-02-11 | STEVENS, CHRISTOPHER JAMES | Chief Operating Officer | Buy | 61,963 | — | — |
| 2026-02-11 | SHAH, GAURAV | CEO | Buy | 870,648 | — | — |
| 2026-02-11 | SHAH, GAURAV | CEO | Buy | 286,028 | — | — |
| 2026-02-11 | RIZVI, SYED ALI-AAMIR | Chief Medical Officer | Buy | 93,037 | — | — |
| 2026-02-11 | RIZVI, SYED ALI-AAMIR | Chief Medical Officer | Buy | 61,963 | — | — |
| 2026-02-11 | MILITELLO, JOHN | See Remarks | Buy | 45,018 | — | — |
| 2026-02-11 | MILITELLO, JOHN | See Remarks | Buy | 29,982 | — | — |
| 2026-02-11 | CHAUDHURI, SARBANI | See Remarks | Buy | 189,076 | — | — |
| 2026-02-11 | CHAUDHURI, SARBANI | See Remarks | Buy | 125,924 | — | — |
| 2026-01-02 | BJORK, ELISABETH | Director | Buy | 10,000 | $3.44 | $34400.00 |
| 2025-11-18 | WILSON, MARTIN | General Counsel | Sale | 1,646 | $2.98 | $4910.02 |
| 2025-11-18 | SHAH, GAURAV | Director, CEO | Sale | 6,276 | $2.98 | $18721.31 |
| 2025-11-18 | SCHWARTZ, JONATHAN DAVID | See Remarks | Sale | 2,545 | $2.98 | $7591.74 |
| 2025-11-18 | MILITELLO, JOHN | See Remarks | Sale | 1,086 | $2.98 | $3239.54 |
| 2025-11-03 | WILSON, MARTIN | General Counsel | Buy | 100,000 | — | — |
| 2025-10-14 | MILITELLO, JOHN | See Remarks | Sale | 19,841 | $3.96 | $78570.36 |
| 2025-10-14 | MILITELLO, JOHN | See Remarks | Sale | 5,514 | $3.97 | $21863.01 |
| 2025-10-14 | MILITELLO, JOHN | See Remarks | Sale | 3,005 | $3.97 | $11929.85 |
| 2025-10-14 | MILITELLO, JOHN | See Remarks | Sale | 558 | $3.98 | $2218.05 |
| 2025-10-06 | RIZVI, SYED ALI-AAMIR | Chief Medical Officer | Buy | 383,854 | — | — |
| 2025-10-06 | RIZVI, SYED ALI-AAMIR | Chief Medical Officer | Buy | 283,018 | — | — |
| 2025-10-06 | RIZVI, SYED ALI-AAMIR | Chief Medical Officer | Buy | 62,893 | — | — |
| 2025-09-24 | FONG, PETER | Director | Buy | 30,000 | — | — |
| 2025-09-24 | FONG, PETER | Director | Buy | 23,333 | — | — |
| 2025-09-19 | RTW, INVESTMENTS, LP | Director, 10% Owner, See remarks | Sale | 1 | — | — |
| 2025-09-19 | RTW, INVESTMENTS, LP | Director, 10% Owner, See remarks | Sale | 1,000,000 | $3.11 | $3.10M |
| 2025-09-19 | RTW, INVESTMENTS, LP | Director, 10% Owner, See remarks | Sale | 59,000 | $3.11 | $183195.00 |
| 2025-09-19 | RTW, INVESTMENTS, LP | Director, 10% Owner, See remarks | Buy | 41,000 | $19.09 | $782755.60 |
| 2025-09-08 | WILSON, MARTIN | General Counsel | Buy | 150,000 | — | — |
| 2025-09-08 | SCHWARTZ, JONATHAN DAVID | See Remarks | Buy | 80,000 | — | — |
| 2025-09-08 | MILITELLO, JOHN | See Remarks | Buy | 40,000 | — | — |
| 2025-08-27 | BJORK, ELISABETH | Director | Buy | 10,000 | $3.41 | $34100.00 |
| 2025-08-19 | WILSON, MARTIN | General Counsel | Sale | 588 | $3.00 | $1761.65 |
| 2025-08-19 | SCHWARTZ, JONATHAN DAVID | See Remarks | Sale | 805 | $3.00 | $2411.78 |
| 2025-08-19 | MILITELLO, JOHN | See Remarks | Sale | 361 | $3.00 | $1081.56 |
| 2025-08-18 | WILSON, MARTIN | General Counsel | Sale | 1,004 | $3.07 | $3077.26 |
| 2025-08-18 | SHAH, GAURAV | Director, CEO | Sale | 2,234 | $3.05 | $6813.70 |
| 2025-08-18 | SCHWARTZ, JONATHAN DAVID | See Remarks | Sale | 1,680 | $3.07 | $5149.20 |
| 2025-08-18 | MILITELLO, JOHN | See Remarks | Sale | 699 | $3.07 | $2142.43 |
| 2025-08-14 | WILSON, MARTIN | General Counsel | Sale | 12,109 | $3.02 | $36557.07 |
| 2025-08-14 | SCHWARTZ, JONATHAN DAVID | See Remarks | Sale | 11,161 | $3.02 | $33695.06 |
| 2025-08-14 | MILITELLO, JOHN | See Remarks | Sale | 7,043 | $3.02 | $21262.82 |
| 2025-08-04 | STEVENS, CHRISTOPHER JAMES | Chief Operating Officer | Buy | 554,071 | — | — |
| 2025-08-04 | STEVENS, CHRISTOPHER JAMES | Chief Operating Officer | Buy | 407,166 | — | — |
| 2025-07-03 | ONDREY, AARON | Chief Financial Officer | Sale | 1,477 | $2.88 | $4256.71 |
| 2025-06-18 | WONG, RODERICK | Director, 10% Owner | Buy | 30,000 | — | — |
| 2025-06-18 | WONG, RODERICK | Director, 10% Owner | Buy | 17,667 | — | — |
| 2025-06-18 | SOUTHWELL, DAVID P | Director | Buy | 30,000 | — | — |
| 2025-06-18 | PRATUMSUWAN, PIRATIP | Director | Buy | 30,000 | — | — |
| 2025-06-18 | MALIK, FADY IBRAHAM | Director | Buy | 30,000 | — | — |
| 2025-06-18 | MAKKER, GOTHAM | Director | Buy | 30,000 | — | — |
| 2025-06-18 | MAKKER, GOTHAM | Director | Buy | 19,434 | — | — |
| 2025-06-18 | GRANADILLO, PEDRO P | Director | Buy | 30,000 | — | — |
| 2025-06-18 | GRANADILLO, PEDRO P | Director | Buy | 24,734 | — | — |
| 2025-06-18 | DOLSTEN, MIKAEL | Director | Buy | 30,000 | — | — |
| 2025-06-18 | BOESS, CARSTEN | Director | Buy | 30,000 | — | — |
| 2025-06-18 | BJORK, ELISABETH | Director | Buy | 30,000 | — | — |
| 2025-05-20 | WILSON, MARTIN | General Counsel | Sale | 587 | $6.45 | $3783.80 |
| 2025-05-20 | SHAH, GAURAV | Director, CEO | Sale | 2,253 | $6.45 | $14522.84 |
| 2025-05-20 | SCHWARTZ, JONATHAN DAVID | See Remarks | Sale | 801 | $6.45 | $5163.25 |
| 2025-05-20 | PATEL, KINNARI | See Remarks | Sale | 767 | $6.45 | $4944.08 |
| 2025-05-20 | MILITELLO, JOHN | See Remarks | Sale | 357 | $6.45 | $2301.22 |
| 2025-05-16 | WILSON, MARTIN | General Counsel | Sale | 946 | $6.53 | $6175.49 |
| 2025-05-16 | SHAH, GAURAV | Director, CEO | Sale | 3,621 | $6.53 | $23637.89 |
| 2025-05-16 | SCHWARTZ, JONATHAN DAVID | See Remarks | Sale | 1,582 | $6.53 | $10327.30 |
| 2025-05-16 | PATEL, KINNARI | See Remarks | Sale | 1,409 | $6.53 | $9197.95 |
| 2025-05-16 | MILITELLO, JOHN | See Remarks | Sale | 655 | $6.53 | $4275.84 |
| 2025-04-22 | MILITELLO, JOHN | See Remarks | Sale | 718 | $7.16 | $5139.44 |
| 2025-04-10 | SHAH, GAURAV | Director, CEO | Buy | 20,000 | $5.08 | $101600.00 |
| 2025-04-09 | PATEL, KINNARI | See Remarks | Buy | 21,099 | $4.70 | $99165.30 |
| 2025-04-04 | ONDREY, AARON | Chief Financial Officer | Sale | 7,489 | $5.29 | $39646.77 |
| 2025-03-05 | DOLSTEN, MIKAEL | Director | Buy | 14,220 | — | — |
| 2025-02-25 | SCHWARTZ, JONATHAN DAVID | See Remarks | Sale | 6,532 | $10.58 | $69108.56 |
| 2025-02-21 | WILSON, MARTIN | General Counsel | Sale | 3,222 | $10.58 | $34088.76 |
| 2025-02-21 | SHAH, GAURAV | Director, CEO | Sale | 16,303 | $10.58 | $172485.74 |
| 2025-02-21 | PATEL, KINNARI | See Remarks | Sale | 6,078 | $10.58 | $64305.24 |
| 2025-02-21 | MILITELLO, JOHN | See Remarks | Sale | 2,737 | $10.58 | $28957.46 |
| 2025-02-11 | WILSON, MARTIN | General Counsel | Buy | 134,642 | — | — |
| 2025-02-11 | WILSON, MARTIN | General Counsel | Buy | 90,358 | — | — |
| 2025-02-11 | SHAH, GAURAV | Director, CEO | Buy | 243,345 | — | — |
| 2025-02-11 | SHAH, GAURAV | Director, CEO | Buy | 81,655 | — | — |
| 2025-02-11 | SCHWARTZ, JONATHAN DAVID | See Remarks | Buy | 119,682 | — | — |
| 2025-02-11 | SCHWARTZ, JONATHAN DAVID | See Remarks | Buy | 80,318 | — | — |
| 2025-02-11 | PATEL, KINNARI | See Remarks | Buy | 172,214 | — | — |
| 2025-02-11 | PATEL, KINNARI | See Remarks | Buy | 57,786 | — | — |
| 2025-02-11 | ONDREY, AARON | Chief Financial Officer | Buy | 134,642 | — | — |
| 2025-02-11 | ONDREY, AARON | Chief Financial Officer | Buy | 90,358 | — | — |
Frequently asked questions
Are RCKT insiders buying or selling?
Over the transactions on record, RCKT insiders have been net buyers, with about $4.27M in stock sold across 49 sales, against 5 open-market purchases.
Does insider selling at RCKT mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which RCKT insiders are selling the most?
Recent selling is concentrated in a few names. RTW, INVESTMENTS, LP accounts for the largest share on record, with about $3.29M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.